Wegovy Side Effects in Women: What's Normal, What's Hair Loss, What's Serious

What are the most common Wegovy side effects?

Most Wegovy side effects come from how the drug works. Semaglutide, the medicine in Wegovy, slows how fast your stomach empties. It also turns down hunger signals in the brain. Together, those two effects explain nearly every common complaint.

The figures below come from Wegovy's main weight-loss trials, as listed in its FDA prescribing information. Each line compares people on Wegovy with people on a placebo, a dummy shot with no medicine in it.

• Nausea: 44% on Wegovy, 16% on placebo. It is usually strongest in the days after each dose increase.
• Diarrhea: 30% on Wegovy, 16% on placebo.
• Vomiting: 24% on Wegovy, 6% on placebo.
• Constipation: 24% on Wegovy, 11% on placebo.
• Belly pain: 20% on Wegovy, 10% on placebo.
• Indigestion, bloating, burping, heartburn: each under 10% on Wegovy.
• Headache, tiredness, dizziness: less common, and more likely when you eat much less than usual.

None of this means something went wrong. The dose goes up slowly on purpose, so your gut has time to adjust. Our Wegovy dosage guide lays out each step.

Stomach side effects made about 4 in 100 people on Wegovy stop for good. On placebo, fewer than 1 in 100 stopped for that reason. So most people who feel these symptoms stay on treatment.

Wegovy pill side effects

The Wegovy pill is a daily semaglutide tablet. The FDA approved it in December 2025 as the first GLP-1 pill for weight management. GLP-1 drugs are the family that Wegovy and Ozempic belong to.

Its label says the common side effects in the pill trial matched the ones above. In that trial, stomach side effects led about 3 in 100 people on the pill to stop, versus 2 in 100 on placebo.

What differs is the routine. You take it each morning on an empty stomach, with up to 4 ounces of water. Then you wait at least 30 minutes before eating, drinking, or taking other pills. Skipping the wait does not cause a new side effect. It just means less of the dose gets absorbed.

How do you manage the common side effects?

A few habits cover most of what shows up in the first weeks.

• Stick to the dose schedule. The steps are spaced out so your gut can adjust. Moving faster tends to backfire.
• Eat smaller, lower-fat meals. Wegovy already slows digestion. A big or fatty meal on top of that is a common nausea trigger.
• Drink enough fluids. This matters most during a stretch of vomiting or diarrhea. It is your best protection against the kidney problem described below.
• Keep the pill routine steady. Take the tablet at the same time each morning and keep the 30-minute wait. Uneven timing makes nausea harder to predict.
• Notice when nausea peaks. Some people do better by moving meals, or by taking the weekly shot earlier in the day.

Are Wegovy side effects different in women, especially in perimenopause?

Yes, a little, and real trial data show it. A pooled analysis, one that combines several trials, compared women and men across Wegovy's main studies.

• Any side effect: 90.5% of women, 83.4% of men.
• A serious side effect: 9.5% of women, 9.1% of men.
• Stopped because of a side effect: 6.1% of women, 4.6% of men.

The gap is not random. Women tend to respond more strongly to these drugs, and stomach side effects track with how much weight someone loses. Women may also have higher drug levels in the blood. More effect brings more side effects. It does not mean Wegovy is less safe for women's bodies.

Perimenopause makes this harder to sort out. Tiredness, stomach upset, and poor sleep already show up in the menopause transition, with no drug involved. So a woman starting Wegovy in her 40s may be sorting two sets of symptoms at once.

A rough rule helps. Stomach symptoms that flare with each dose increase and ease within a week or two are more likely Wegovy. Tiredness or mood shifts that come with hot flashes or cycle changes more likely come from perimenopause.

Bones: a finding women should know

SELECT was Wegovy's large heart trial. In it, women on Wegovy had more hip and pelvis fractures than women on placebo. The rate was 1% on Wegovy, versus 0.2% on placebo.

That fits what happens in the years around menopause. Losing weight puts less load on your bones. It also lowers the estrogen that fat tissue makes, just as the ovaries make less. Strength training and weight-bearing exercise help protect bone. A bone density scan, called a DXA scan, shows where you start.

Muscle

Muscle tells a similar story. In a body-scan sub-study of the STEP 1 trial, about 40% of the weight people lost was lean mass, not fat. Lean mass means muscle, bone, and water. That matters more when perimenopause is already wearing down muscle. See GLP-1s and muscle loss in perimenopause for what helps protect it.

One gap remains. No trial has yet compared Wegovy side effects before and after menopause. That means thinner data, not a hidden danger.

Does Wegovy cause hair loss?

Not directly. Nothing shows that semaglutide acts on hair follicles. What some people get instead is telogen effluvium. That is temporary, all-over shedding set off by fast weight loss, whatever the cause.

Here is how it happens. Quick weight loss pushes many hairs into a resting phase at the same time. A few months later, those resting hairs fall out together instead of a few at a time.

In Wegovy's main trials, 3% of people on the drug reported hair loss. On placebo, 1% did. In one analysis of the trials, hair loss reached 5.3% among people who lost more than 20% of their weight. That is about double the rate in people who lost less.

Shedding tends to start a few months in, often peaking around months four to six. For most women, it stops on its own. Hair usually fills back in over the following months as weight loss slows.

If you already notice perimenopausal thinning, another cause may be at work too. See perimenopause hair loss for what else can drive it.

What are the worst, most serious side effects of Wegovy?

Below the everyday stomach complaints sits a shorter list of rare but serious risks. They are the reason for the warnings in Wegovy's FDA prescribing information.

• Thyroid C-cell tumors. This is the boxed warning, the strongest warning the FDA puts on a label. Semaglutide caused these tumors in rodents. Whether it does in humans is unknown. Wegovy is off-limits if you or a family member had medullary thyroid carcinoma or MEN 2, an inherited tumor condition.
• Gallbladder disease. Gallstones affected 1.6% of adults on the Wegovy shot, versus 0.7% on placebo. Gallbladder inflammation affected 0.6%, versus 0.2%. Fast weight loss itself raises this risk.
• Pancreatitis. This is inflammation of the pancreas. It is rare. In the weight-loss trials, doctors confirmed it in 4 of about 2,100 people on Wegovy. On placebo, it was 1 of about 1,300.
• Low blood sugar. The risk rises if you also take insulin or a sulfonylurea, a type of diabetes pill. Your prescriber will usually lower that other drug first.
• Kidney injury. Most cases came with dehydration from vomiting or diarrhea. That is why fluids matter during a rough stretch.
• Eye problems in type 2 diabetes. A fast drop in blood sugar can briefly worsen diabetic retinopathy, damage to the back of the eye. People with that history need their eyes watched.
• A faster heartbeat. Resting heart rate rose by a few beats per minute on average.
• Surgery and sedation. Food can stay in the stomach longer. That raises the risk of breathing it into the lungs under anesthesia, so tell the team before any procedure.

One warning is gone. In February 2026, the FDA removed the warning about suicidal thoughts from Wegovy's label.

Which side effects need same-day medical attention?

Everyday nausea and bloating are one thing. The symptoms below are different. They overlap with the serious risks and deserve same-day care, not a routine message.

• Severe belly pain that won't let up, especially if it spreads to your back, with or without vomiting. This can mean pancreatitis.
• Pain in the upper right belly, fever, or yellow skin or eyes. This can mean a gallbladder problem.
• A new lump in your neck, lasting hoarseness, trouble swallowing, or shortness of breath. These are the thyroid symptoms the FDA label names.
• Signs of severe dehydration, such as peeing much less, dizziness when you stand, or confusion. Watch for this after several days of vomiting or diarrhea.
• Signs of severe low blood sugar if you take insulin or a sulfonylurea, such as shakiness, sweating, or confusion that food does not fix.
• Swelling of the face, lips, tongue, or throat, or trouble breathing. This can mean a severe allergic reaction.
• Sudden changes in vision, especially if you have type 2 diabetes.

Does Wegovy cause cancer?

The boxed warning often gets summed up online as "cancer risk." That overstates it. The warning covers only medullary thyroid carcinoma, a rare type of thyroid cancer. It rests on rodent studies.

It does not cover the far more common types of thyroid cancer. The FDA label says it is unknown whether semaglutide causes these tumors in people. Years into the drug's use, cancer researchers have found no case of it causing thyroid cancer in people.

Wider reviews of the whole GLP-1 drug family have generally found no rise in overall cancer rates. Some point to lower rates of certain obesity-related cancers, likely because weight loss itself lowers risk. Researchers are still watching as more years of use add up.

The practical takeaway is narrow. If you or a family member had medullary thyroid carcinoma or MEN 2, Wegovy is not an option. Outside that history, current evidence does not point to cancer as the risk to worry about.

Is Wegovy actually safe?

Wegovy has its own FDA approval for long-term weight management. That matters more than it seems. Ozempic is the same medicine, approved for type 2 diabetes. Using Ozempic for weight loss is off-label, meaning outside its approved use.

Wegovy's safety data come from its own trials in people with overweight or obesity, a program called STEP. For the diabetes-trial picture on the same molecule, see Ozempic's side effects. For the molecule across all its brands, see semaglutide side effects.

In the main weight-loss trials, 6.8% of people on Wegovy stopped because of a side effect. On placebo, 3.2% stopped. Stomach symptoms explain most of that gap.

SELECT then took a much larger, longer look. It enrolled more than 17,000 adults with overweight or obesity and existing heart disease. The typical follow-up was about three and a half years. Semaglutide lowered their risk of heart attack, stroke, and death from heart disease.

What are the long-term side effects of Wegovy, and what is still being studied?

Wegovy has more long-term data than many people assume. STEP 1 ran 68 weeks, and its extension tracked people after they stopped. SELECT followed its patients for years.

A few questions are still open.

• Bone and muscle over many years. Most body-scan data cover about the first year of treatment.
• The thyroid signal. Researchers keep checking whether the rodent finding matters in humans as years of use add up.
• Stopping. In the STEP 1 extension, weight and metabolic markers drifted back after people stopped. That reflects how the drug works, not a hidden danger.
• The pill. It was approved in December 2025, so it has little real-world history yet. It is a new form of a well-studied medicine, not an unknown one.

For the same questions across the whole drug family, see GLP-1 side effects.

Where to get Wegovy with support if a side effect isn't settling

If a symptom drags on past the first couple of months, support matters as much as price. Here is the short version.

• Lowest brand-name price: NovoCare, Wegovy's maker selling direct.
• Most support and insurance help: Ro Body.
• Lowest monthly cost, compounded: Mochi Health.

Ro Body includes an insurance concierge, a person who handles the insurance paperwork for you. It also includes one metabolic lab test when your provider orders it. So a side effect that needs a basic blood panel is often already covered. Ro prescribes brand-name Wegovy only, never a compounded version.

NovoCare is Novo Nordisk, Wegovy's maker, selling to you directly. There is no membership fee on top. It does not include a clinician or lab tests, so bloodwork is a step you arrange yourself.

Mochi Health and Henry Meds both offer compounded semaglutide. Compounded means a licensed pharmacy mixes the same active molecule. It is not the FDA-approved Wegovy pen or pill. Mochi can also prescribe brand-name Wegovy, at a separate price.

• Mochi Health: about $140–$270/mo all-in for compounded semaglutide. The price rises with your dose.
• Henry Meds: about $250/mo for the tablet, or about $300/mo for the injection. No membership fee · About $200/mo for the injection on a 12-month prepay.